Skip header and navigation

Refine By

3391 records – page 1 of 340.

1st European Congress on Parenteral and Enteral Nutrition. Stockholm, Sweden. September 2--5, 1979.

https://arctichealth.org/en/permalink/ahliterature62440
Source
JPEN J Parenter Enteral Nutr. 1979 Jul-Aug;3(4):289-316
Publication Type
Conference/Meeting Material
Source
JPEN J Parenter Enteral Nutr. 1979 Jul-Aug;3(4):289-316
Language
English
Publication Type
Conference/Meeting Material
Keywords
Congresses
Enteral Nutrition
Europe
Humans
Metabolism
Nutrition
Parenteral Nutrition
Sweden
PubMed ID
39184 View in PubMed
Less detail

2nd-generation HIV surveillance and injecting drug use: uncovering the epidemiological ice-berg.

https://arctichealth.org/en/permalink/ahliterature84543
Source
Int J Public Health. 2007;52(3):166-72
Publication Type
Article
Date
2007
Author
Reintjes Ralf
Wiessing Lucas
Author Affiliation
Department of Public Health, Faculty Life Sciences, Hamburg University of Applied Sciences, Hamburg, Germany. Ralf.Reintjes@rzbd.haw-hamburg.de
Source
Int J Public Health. 2007;52(3):166-72
Date
2007
Language
English
Publication Type
Article
Keywords
Acquired Immunodeficiency Syndrome - epidemiology - prevention & control - therapy
Cost-Benefit Analysis
Europe - epidemiology
HIV Infections - epidemiology - prevention & control - therapy
Hepatitis C - epidemiology
Humans
Norway - epidemiology
Population Surveillance
Prevalence
Risk factors
Risk-Taking
Substance Abuse, Intravenous - epidemiology
Turkey - epidemiology
Abstract
OBJECTIVES: HIV/AIDS surveillance methods are under revision as the diversity of HIV epidemics is becoming more apparent. The so called "2nd generation surveillance (SGS) systems" aim to enhance surveillance by broadening the range of indicators to prevalence, behaviors and correlates, for a better understanding and a more complete and timely awareness of evolving epidemics. METHODS: Concepts of HIV SGS are reviewed with a special focus on injecting drug users, a major at-risk and hard to reach group in Europe, a region with mainly low or concentrated epidemics. RESULTS: The scope of HIV/AIDS surveillance needs to be broadened following principles of SGS. Specifically for IDUs we propose including hepatitis C data as indicator for injecting risk in routine systems like those monitoring sexually transmitted infections and information on knowledge and attitudes as potential major determinants of risk behavior. CONCLUSIONS: The suggested approach should lead to more complete and timely information for public health interventions, however there is a clear need for comparative validation studies to assess the validity, reliability and cost-effectiveness of traditional and enhanced HIV/AIDS surveillance systems.
PubMed ID
17958283 View in PubMed
Less detail

4th European Public Health Conference 2011 in Copenhagen: Public Health and Welfare--Welfare Development and Health .

https://arctichealth.org/en/permalink/ahliterature137620
Source
Scand J Public Health. 2011 Feb;39(1):1-2
Publication Type
Article
Date
Feb-2011
Author
Finn Kamper-Jørgensen
Source
Scand J Public Health. 2011 Feb;39(1):1-2
Date
Feb-2011
Language
English
Publication Type
Article
Keywords
Denmark
Europe
Health promotion
Humans
Public Health
World Health
PubMed ID
21266586 View in PubMed
Less detail

[4 years after Chernobyl: medical repercussions]

https://arctichealth.org/en/permalink/ahliterature25355
Source
Bull Cancer. 1990;77(5):419-28
Publication Type
Article
Date
1990
Author
D. Hubert
Source
Bull Cancer. 1990;77(5):419-28
Date
1990
Language
French
Publication Type
Article
Keywords
Abnormalities, Radiation-Induced - epidemiology
Abortion, Habitual - epidemiology
Blood Cell Count
Bone Marrow Transplantation
Decontamination - methods
Diarrhea - etiology
English Abstract
Europe
Female
Humans
Male
Nuclear Reactors
Pregnancy
Prognosis
Psychophysiologic Disorders - etiology
Pulmonary Fibrosis - etiology
Radiation Dosage
Radiation Injuries - complications - epidemiology - therapy
Skin - radiation effects
Triage
Ukraine
Abstract
The nuclear accident at Chernobyl accounted for an acute radiation syndrome in 237 persons on the site. Triage was the initial problem and was carried out according to clinical and biological criteria; evaluating the doses received was based on these criteria. Thirty one persons died and only 1 survived a dose higher than 6 Gy. Skin radiation burns which were due to inadequate decontamination, greatly worsened prognosis. The results of 13 bone marrow transplantations were disappointing, with only 2 survivors. Some time after the accident, these severely irradiated patients are mainly suffering from psychosomatic disorders, in the USSR, some areas have been significantly contaminated and several measures were taken to mitigate the impact on population: evacuating 135,000 persons, distributing prophylactic iodine, establishing standards and controls on foodstuff. Radiation phobia syndrome which developed in many persons, is the only sanitary effect noticed up to now. Finally, in Europe, there was only an increase in induced abortions and this was totally unwarranted. If we consider the risk of radiation induced cancer, an effect might not be demonstrated.
PubMed ID
2205311 View in PubMed
Less detail

The 6-F nitinol TrapEase inferior vena cava filter: results of a prospective multicenter trial.

https://arctichealth.org/en/permalink/ahliterature195125
Source
J Vasc Interv Radiol. 2001 Mar;12(3):299-304
Publication Type
Article
Date
Mar-2001
Author
H. Rousseau
P. Perreault
P. Otal
L. Stockx
J. Golzarian
V. Oliva
P. Reynaud
F. Raat
F. Szatmari
G. Santoro
G. Emanuelli
M. Nonent
Y. Hoogeveen
Author Affiliation
Radiology Department, CHU Rangueil, Toulouse, France. rousseau.h@chu-toulouse.fr
Source
J Vasc Interv Radiol. 2001 Mar;12(3):299-304
Date
Mar-2001
Language
English
Publication Type
Article
Keywords
Aged
Alloys
Canada
Equipment Design
Europe
Female
Follow-Up Studies
Humans
Male
Prospective Studies
Pulmonary Embolism - prevention & control
Risk
Time Factors
Vena Cava Filters - adverse effects
Venous Thrombosis - epidemiology
Abstract
The authors report the first results of a new 6-F symmetrically designed permanent nitinol inferior vena cava (IVC) filter, the Cordis TrapEase, evaluated in a multicenter prospective study with 6-months of follow-up.
A total of 65 patients (29 men, 36 women) who ranged in age from 37 to 96 years (mean age, 68 years) and who were at high risk of pulmonary embolism (PE) were enrolled in 12 centers in Europe and Canada. The study was approved by the institutional review boards at all centers. Study objectives were to evaluate filter effectiveness, filter stability, and caval occlusion. Indications for filter placement were deep vein thrombosis with recurrent thromboembolism and/or free-floating thrombus with contraindication to anticoagulation in 37 patients, and complications in achieving adequate anticoagulation in 28 patients. Follow-up included clinical examination, plain film, Doppler ultrasound, CT scan, and nuclear medicine.
The analysis of the data revealed a technical success of 95.4% (three filter-system related implantations not at the intended site, no events of filter tilting) and a clinical success of 100% at 6 months (no cases of symptomatic PE), the study primary endpoint. There were no cases (0%) of filter migration, insertion site thrombosis, filter fracture, or vessel wall perforation. During the study period, there were two cases of filter thrombosis: one case of early symptomatic thrombosis that was successfully treated in the hospital, and one case of nonsymptomatic filter thrombosis detected at 1-month follow-up, with spontaneous recanalization at 3 months. In the latter patient, some residual thrombus was still detected at 6 months. Of the study population of 65 patients, there were 23 deaths. These deaths were not related to the device or the implantation procedure but to the underlying disease process.
This study demonstrates the new nitinol permanent IVC filter to be a safe and an effective device, with a low overall complication rate, for use in patients with thromboembolic disease at high risk of PE.
PubMed ID
11287505 View in PubMed
Less detail

The 6th Klaas Breur memorial lecture, 1987. The Chernobyl accident--impact Western Europe.

https://arctichealth.org/en/permalink/ahliterature25858
Source
Radiother Oncol. 1988 May;12(1):1-13
Publication Type
Article
Date
May-1988

The 7th European Placenta Group Meeting, Vigsø, Denmark, 13-17 December 1997.

https://arctichealth.org/en/permalink/ahliterature64188
Source
Placenta. 1998 May;19(4):341-4
Publication Type
Conference/Meeting Material
Date
May-1998
Author
C H Graham
Author Affiliation
Department of Anatomy and Cell Biology, Queen's University, Kingston, Ontario, Canada.
Source
Placenta. 1998 May;19(4):341-4
Date
May-1998
Language
English
Publication Type
Conference/Meeting Material
Keywords
Animals
Disease Transmission, Vertical
Drug Delivery Systems
Europe
Female
Humans
Maternal-Fetal Exchange
Pharmacokinetics
Placenta - physiology
Pregnancy
PubMed ID
9735019 View in PubMed
Less detail

A 15-month evaluation of the effects of repeated subgingival minocycline in chronic adult periodontitis.

https://arctichealth.org/en/permalink/ahliterature201582
Source
J Periodontol. 1999 Jun;70(6):657-67
Publication Type
Article
Date
Jun-1999
Author
D. van Steenberghe
B. Rosling
P O Söder
R G Landry
U. van der Velden
M F Timmerman
E F McCarthy
G. Vandenhoven
C. Wouters
M. Wilson
J. Matthews
H N Newman
Author Affiliation
Catholic University, Leuven, Belgium.
Source
J Periodontol. 1999 Jun;70(6):657-67
Date
Jun-1999
Language
English
Publication Type
Article
Keywords
Adult
Aggregatibacter actinomycetemcomitans - drug effects
Analysis of Variance
Anti-Bacterial Agents - administration & dosage
Campylobacter - drug effects
Canada
Chronic Disease
Colony Count, Microbial
Dental Plaque Index
Dental Scaling
Double-Blind Method
Eikenella corrodens - drug effects
Europe
Female
Fusobacterium nucleatum - drug effects
Humans
Longitudinal Studies
Male
Middle Aged
Minocycline - administration & dosage
Ointments
Periodontal Index
Periodontal Pocket - drug therapy - microbiology
Periodontitis - drug therapy - microbiology
Porphyromonas gingivalis - drug effects
Prevotella intermedia - drug effects
Statistics, nonparametric
Treatment Outcome
Treponema - drug effects
Abstract
A double-blind, randomized, parallel, comparative study was designed to evaluate the long-term safety and efficacy of subgingivally administered minocycline ointment versus a vehicle control.
One hundred four patients (104) with moderate to severe adult periodontitis (34 to 64 years of age; mean 46 years) were enrolled in the study. Following scaling and root planing, patients were randomized to receive either 2% minocycline ointment or a matched vehicle control. Study medication was administered directly into the periodontal pocket with a specially designed, graduated, disposable applicator at baseline; week 2; and at months 1, 3, 6, 9, and 12. Scaling and root planing was repeated at months 6 and 12. Standard clinical variables (including probing depth and attachment level) were evaluated at baseline and at months 1, 3, 6, 9, 12, and 15. Microbiological sampling using DNA probes was done at baseline; at week 2; and at months 1, 3, 6, 9, 12, and 15.
Both treatment groups showed significant and clinically relevant reductions in the numbers of each of the 7 microorganisms measured during the entire 15-month study period. When differences were detected, sites treated with minocycline ointment always produced statistically significantly greater reductions than sites which received the vehicle control. For initial pockets > or =5 mm, a mean reduction in probing depth of 1.9 mm was seen in the test sites, versus 1.2 mm in the control sites. Sites with a baseline probing depth > or =7 mm and bleeding index >2 showed an average of 2.5 mm reduction with minocycline versus 1.5 mm with the vehicle. Gains in attachment (0.9 mm and 1.1 mm) were observed in minocycline-treated sites, with baseline probing depth > or =5 mm and > or =7 mm, respectively, compared with 0.5 mm and 0.7 mm gain at control sites. Subgingival administration of minocycline ointment was well tolerated.
Overall, the results demonstrate that repeated subgingival administration of minocycline ointment in the treatment of adult periodontitis is safe and leads to significant adjunctive improvement after subgingival instrumentation in both clinical and microbiologic variables over a 15-month period.
PubMed ID
10397521 View in PubMed
Less detail

24th European Academy of Dermatology and Venereology.

https://arctichealth.org/en/permalink/ahliterature278271
Source
Immunotherapy. 2016;8(4):395-7
Publication Type
Conference/Meeting Material
Date
2016
Author
Anja C Rasch
Source
Immunotherapy. 2016;8(4):395-7
Date
2016
Language
English
Publication Type
Conference/Meeting Material
Keywords
Animals
Denmark
Dermatologists
Dermatology - trends
Europe
Humans
Skin Diseases - immunology
Societies, Scientific
Venereology - trends
Abstract
The 24th European Academy of Dermatology and Venereology was held in Copenhagen, Denmark, from 7-11 October 2015. It has become Europe's biggest meeting of its kind with roughly 10,000 participants, approximately 3000 abstracts and about 180 exhibitors from all over the world. The organizers offer a venue for the latest cutting edge research and newest developments. Thus, their goal is to foster progress in clinical care and promote scientific excellence related to dermatovenereology for the benefit of patients with skin diseases.
PubMed ID
26973121 View in PubMed
Less detail

3391 records – page 1 of 340.